Gordon Gary B.
Insider CIK 1811354 · AYLA Chief Medical Officer · TLSI Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TLSI TriSalus Life Sciences, In | P Buy | 2026-05-15 | 2026-05-18 | 10,000 | $2.46 | $24.6K | 72,510 | SEC↗ |
| TLSI TriSalus Life Sciences, In | A Award deriv | 2026-05-14 | 2026-05-15 | 56,403 | — | $0 | 112,653 | SEC↗ |
| TLSI TriSalus Life Sciences, In | A Award | 2026-05-14 | 2026-05-15 | 28,201 | — | $0 | 37,957 | SEC↗ |
| TLSI TriSalus Life Sciences, In | A Award | 2026-05-14 | 2026-05-15 | 24,553 | — | $0 | 62,510 | SEC↗ |
| TLSI TriSalus Life Sciences, In | P Buy | 2026-02-23 | 2026-02-23 | 9,756 | $4.10 | $40.0K | 9,756 | SEC↗ |
| TLSI TriSalus Life Sciences, In | A Award deriv | 2025-06-12 | 2025-06-27 | 15,000 | — | $0 | 56,250 | SEC↗ |
| TLSI TriSalus Life Sciences, In | A Award deriv | 2025-01-29 | 2025-01-31 | 6,250 | — | $0 | 6,250 | SEC↗ |
| TLSI TriSalus Life Sciences, In | A Award deriv | 2025-01-29 | 2025-01-31 | 35,000 | — | $0 | 35,000 | SEC↗ |
| AYLA Old Ayala, Inc | D To issuer deriv | 2023-01-19 | 2023-01-23 | 19,170 | — | $0 | 0 | SEC↗ |
| AYLA Old Ayala, Inc | D To issuer deriv | 2023-01-19 | 2023-01-23 | 31,950 | — | $0 | 0 | SEC↗ |
| AYLA Old Ayala, Inc | D To issuer deriv | 2023-01-19 | 2023-01-23 | 89,000 | — | $0 | 0 | SEC↗ |
| AYLA Old Ayala, Inc | D To issuer | 2023-01-19 | 2023-01-23 | 58,520 | — | $0 | 0 | SEC↗ |
| AYLA Ayala Pharmaceuticals, Inc | A Award | 2022-05-16 | 2022-05-16 | 50,000 | — | $0 | 58,520 | SEC↗ |
| AYLA Ayala Pharmaceuticals, Inc | A Award deriv | 2022-01-03 | 2022-01-05 | 31,950 | — | $0 | 31,950 | SEC↗ |
| AYLA Ayala Pharmaceuticals, Inc | M Exercise deriv | 2021-02-24 | 2021-02-26 | 3,000 | — | $0 | 89,000 | SEC↗ |
| AYLA Ayala Pharmaceuticals, Inc | M Exercise | 2021-02-24 | 2021-02-26 | 3,000 | $5.16 | $15.5K | 11,520 | SEC↗ |
| AYLA Ayala Pharmaceuticals, Inc | S Sale | 2021-02-24 | 2021-02-26 | 3,000 | $17.46 | $52.4K | 8,520 | SEC↗ |
| AYLA Ayala Pharmaceuticals, Inc | M Exercise deriv | 2021-01-20 | 2021-01-22 | 3,000 | — | $0 | 92,000 | SEC↗ |
| AYLA Ayala Pharmaceuticals, Inc | M Exercise | 2021-01-20 | 2021-01-22 | 3,000 | $5.16 | $15.5K | 11,520 | SEC↗ |
| AYLA Ayala Pharmaceuticals, Inc | S Sale | 2021-01-20 | 2021-01-22 | 3,000 | $15.03 | $45.1K | 8,520 | SEC↗ |
| AYLA Ayala Pharmaceuticals, Inc | A Award deriv | 2021-01-04 | 2021-01-06 | 19,170 | — | $0 | 19,170 | SEC↗ |
| AYLA Ayala Pharmaceuticals, Inc | A Award | 2021-01-04 | 2021-01-06 | 8,520 | — | $0 | 8,520 | SEC↗ |